Publicaciones en colaboración con investigadores/as de Medical University of Vienna (44)

2024

  1. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches

    Journal of Extracellular Vesicles, Vol. 13, Núm. 2

2022

  1. Are Physicochemical Properties Shaping the Allergenic Potency of Animal Allergens?

    Clinical Reviews in Allergy and Immunology, Vol. 62, Núm. 1

  2. Are Physicochemical Properties Shaping the Allergenic Potency of Plant Allergens?

    Clinical Reviews in Allergy and Immunology, Vol. 62, Núm. 1, pp. 37-63

  3. Clinical trials in pediatric ALS: a TRICALS feasibility study

    Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, Vol. 23, Núm. 7-8, pp. 481-488

  4. First-in-human phase I clinical trial of a TLR4-binding DNA aptamer, ApTOLL: Safety and pharmacokinetics in healthy volunteers

    Molecular Therapy - Nucleic Acids, Vol. 28, pp. 124-135

2021

  1. ARIA-EAACI care pathways for allergen immunotherapy in respiratory allergy

    Clinical and Translational Allergy, Vol. 11, Núm. 4

  2. Allergens and their associated small molecule ligands—their dual role in sensitization

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 8, pp. 2367-2382

  3. Biologicals in atopic disease in pregnancy: An EAACI position paper

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 1, pp. 71-89

  4. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

2020

  1. Anwendung von biologika bei allergischen und Typ-2-entzündlichen Erkrankungen in der aktuellen COVID-19-Pandemie

    Allergologie, Vol. 43, Núm. 7, pp. 255-271

  2. Assessing autophagy in archived tissue or how to capture autophagic flux from a tissue snapshot

    Biology, Vol. 9, Núm. 3

  3. CRISPR/Cas9-generated models uncover therapeutic vulnerabilities of del(11q) CLL cells to dual BCR and PARP inhibition

    Leukemia, Vol. 34, Núm. 6, pp. 1599-1612

  4. EAACI Research and Outreach Committee: Improving standards and facilitating global collaboration through a Research Excellence Network

    Allergy: European Journal of Allergy and Clinical Immunology

  5. High throughput single-cell detection of multiplex CRISPR-edited gene modifications

    Genome Biology, Vol. 21, Núm. 1

  6. In-vivo diagnostic test allergens in Europe: A call to action and proposal for recovery plan—An EAACI position paper

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 9, pp. 2161-2169

2019

  1. A mouse model to assess STAT3 and STAT5A/B combined inhibition in health and disease conditions

    Cancers, Vol. 11, Núm. 9

  2. Prioritizing research challenges and funding for allergy and asthma and the need for translational research—The European Strategic Forum on Allergic Diseases

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 74, Núm. 11, pp. 2064-2076

2018

  1. Afatinib restrains K-RAS-driven lung tumorigenesis

    Science Translational Medicine, Vol. 10, Núm. 44

  2. Peanut lipids display potential adjuvanticity by triggering a pro-inflammatory response in human keratinocytes

    Allergy: European Journal of Allergy and Clinical Immunology

  3. Virus-like particles (VLP) in prophylaxis and immunotherapy of allergic diseases

    Allergo Journal International, Vol. 27, Núm. 8, pp. 245-255